BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Salminen E, Palmu S, Vahlberg T, Roberts PJ, Söderström KO. Increased proliferation activity measured by immunoreactive Ki67 is associated with survival improvement in rectal/recto sigmoid cancer. World J Gastroenterol 2005; 11(21): 3245-3249 [PMID: 15929175 DOI: 10.3748/wjg.v11.i21.3245]
URL: https://www.wjgnet.com/1007-9327/full/v11/i21/3245.htm
Number Citing Articles
1
Alan P. Venook, Donna Niedzwiecki, Margarita Lopatin, Xing Ye, Mark Lee, Paula N. Friedman, Wendy Frankel, Kim Clark-Langone, Carl Millward, Steven Shak, Richard M. Goldberg, Najjia N. Mahmoud, Robert S. Warren, Richard L. Schilsky, Monica M. Bertagnolli. Biologic Determinants of Tumor Recurrence in Stage II Colon Cancer: Validation Study of the 12-Gene Recurrence Score in Cancer and Leukemia Group B (CALGB) 9581Journal of Clinical Oncology 2013; 31(14): 1775 doi: 10.1200/JCO.2012.45.1096
2
Nathaniel Melling, Charlotte Marie Kowitz, Ronald Simon, Carsten Bokemeyer, Luigi Terracciano, Guido Sauter, Jakob Robert Izbicki, Andreas Holger Marx. High Ki67 expression is an independent good prognostic marker in colorectal cancerJournal of Clinical Pathology 2016; 69(3): 209 doi: 10.1136/jclinpath-2015-202985
3
Jetsada Ruangsuriya, Jirapast Sichaem, Apichat Tantraworasin, Somcharoen Saeteng, Phanchaporn Wongmaneerung, Angkhana Inta, Neal M. Davies, Kewalin Inthanon, Mohamed Addi. Phytochemical Profiles and Anticancer Effects of Calophyllum inophyllum L. Extract Relating to Reactive Oxygen Species Modulation on Patient-Derived Cells from Breast and Lung CancersScientifica 2023; 2023: 1 doi: 10.1155/2023/6613670
4
Piotr Daniel, Malgorzata Wagrowska-Danilewicz, Marian Danilewicz, Olga Stasikowska, Ewa Malecka-Panas. Transforming growth factor beta 1 and metalloproteinase-9 overexpression in colorectal cancer (CC) and adenomaInternational Journal of Colorectal Disease 2007; 22(10): 1165 doi: 10.1007/s00384-007-0296-9
5
Anas Taha, Stephanie Taha-Mehlitz, Stephanie Petzold, Sergey L. Achinovich, Dmitry Zinovkin, Bassey Enodien, Md Zahidul I. Pranjol, Eldar A. Nadyrov. Prognostic Value of Immunohistochemical Markers for Locally Advanced Rectal CancerMolecules 2022; 27(3): 596 doi: 10.3390/molecules27030596
6
M. S. Reimers, E. C. M. Zeestraten, T. C. van Alphen, J. W. T. Dekker, H. Putter, S. Saadatmand, G. J. Liefers, C. J. H. van de Velde, P. J. K. Kuppen. Combined analysis of biomarkers of proliferation and apoptosis in colon cancer: an immunohistochemistry-based study using tissue microarrayInternational Journal of Colorectal Disease 2014; 29(9): 1043 doi: 10.1007/s00384-014-1930-y
7
Anna Sadowska, Diana Sawicka, Katarzyna Godlewska, Katarzyna Guzińska-Ustymowicz, Ewa Zapora, Emilia Sokołowska, Halina Car. Beneficial Proapoptotic Effect of Heterobasidion Annosum Extract in Colorectal Cancer Xenograft Mouse ModelMolecules 2023; 28(3): 1352 doi: 10.3390/molecules28031352
8
Aldona Kasprzak. Prognostic Biomarkers of Cell Proliferation in Colorectal Cancer (CRC): From Immunohistochemistry to Molecular Biology TechniquesCancers 2023; 15(18): 4570 doi: 10.3390/cancers15184570
9
Shibao Li, Zhiyuan Wu, Yuming Chen, Zhihua Kang, Hua Wang, Ping He, Xinju Zhang, Tingting Hu, Qunfeng Zhang, Yanqun Cai, Xiao Xu, Ming Guan. Diagnostic and prognostic value of tissue and circulating levels of Ephrin-A2 in prostate cancerTumor Biology 2016; 37(4): 5365 doi: 10.1007/s13277-015-4398-7
10
I. Tica Sedlar, J. Petricevic, M. Saraga-Babic, I. Pintaric, K. Vukojevic. Apoptotic pathways and stemness in the colorectal epithelium and lamina propria mucosae during the human embryogenesis and carcinogenesisActa Histochemica 2016; 118(7): 693 doi: 10.1016/j.acthis.2016.08.004
11
Marcello Deraco, Antonello Cabras, Dario Baratti, Shigeki Kusamura. Immunohistochemical Evaluation of Minichromosome Maintenance Protein 7 (MCM7), Topoisomerase IIα, and Ki-67 in Diffuse Malignant Peritoneal Mesothelioma Patients Using Tissue MicroarrayAnnals of Surgical Oncology 2015; 22(13): 4344 doi: 10.1245/s10434-015-4498-z
12
Peter M. Wilson, Pierre Bohanes, Heinz-Josef Lenz. Using The Colon Cancer Multigene Recurrence Score to Determine Risk: Prognostic Milestone or a Step in the Right Direction?Current Colorectal Cancer Reports 2010; 6(4): 183 doi: 10.1007/s11888-010-0064-z
13
K Talvinen, H Karra, S Hurme, M Nykänen, A Nieminen, J Anttinen, T Kuopio, P Kronqvist. Securin promotes the identification of favourable outcome in invasive breast cancerBritish Journal of Cancer 2009; 101(6): 1005 doi: 10.1038/sj.bjc.6605237
14
Ø Fluge, K Gravdal, E Carlsen, B Vonen, K Kjellevold, S Refsum, R Lilleng, T J Eide, T B Halvorsen, K M Tveit, A P Otte, L A Akslen, O Dahl. Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosisBritish Journal of Cancer 2009; 101(8): 1282 doi: 10.1038/sj.bjc.6605333
15
Hong Lei, Shan Yan, Yin He, Ning Xu, Min Zhao, Chun Yu, Hong Li, Sai Kuang, Zhan Cui, Jing Fang. Ki67 testing in the clinical management of patients with non‑metastatic colorectal cancer: Detecting the optimal cut‑off value based on the Restricted Cubic Spline modelOncology Letters 2022; 24(6) doi: 10.3892/ol.2022.13540
16
Vitalii V. Zvirych, Yuriy I. Michailovich, Oleksandr І. Gorbach, Natalia М. Khranovska. IMMUNOHISTOCHEMICAL AND GENETIC PROGNOSTIC FACTORS OF NEOADJUVANT CHEMORADIOTHERAPY EFFICАCY IN PERSONALIZED TREATMENT OF LOCAL ADVANCED RECTAL CANCERWiadomości Lekarskie 2020; 73(3): 589 doi: 10.36740/WLek202003136
17
Rima A. Safadi, Basma F. Quda, Huda M. Hammad. Immunohistochemical expression of K6, K8, K16, K17, K19, maspin, syndecan-1 (CD138), α-SMA, and Ki-67 in ameloblastoma and ameloblastic carcinoma: diagnostic and prognostic correlationsOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2016; 121(4): 402 doi: 10.1016/j.oooo.2015.11.015
18
Pan Li, Zhi-Tao Xiao, Todd A. Braciak, Qing-Jan Ou, Gong Chen, Fuat S. Oduncu. Association between Ki67 Index and Clinicopathological Features in Colorectal CancerOncology Research and Treatment 2016; 39(11): 696 doi: 10.1159/000450623
19
Zhao-Wen Luo, Ming-Gu Zhu, Zhi-Qiao Zhang, Feng-Jun Ye, Wen-Heng Huang, Xue-Zhang Luo. Increased expression of Ki-67 is a poor prognostic marker for colorectal cancer patients: a meta analysisBMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5324-y
20
Yu-Feng Yang, Xi-Ying Zhang, Mei Yang, Ze-Hua He, Ning-Fu Peng, Shu-Rui Xie, Yan-Fang Xie. Prognostic Role of Nucleophosmin in Colorectal CarcinomasAsian Pacific Journal of Cancer Prevention 2014; 15(5): 2021 doi: 10.7314/APJCP.2014.15.5.2021
21
Wen-juan Ma, Yukun Chen, Jian-hong Peng, Chaoming Tang, Ling Zhang, Min Liu, Shanshan Hu, Haineng Xu, Hua Tan, Yangkui Gu, Zhi-zhong Pan, Gong Chen, Zhong-guo Zhou, Rong-xin Zhang. Stage IV colon cancer patients without DENND2D expression benefit more from neoadjuvant chemotherapyCell Death & Disease 2022; 13(5) doi: 10.1038/s41419-022-04885-8
22
Vikram Narang, Namrata Puri, Aminder Singh, Neena Sood, Vineeta Malhotra. COLORECTAL CANCER IN INDIA: AN ICEBERG ANALYSIS FROM NORTH INDIAJournal of Evolution of Medical and Dental Sciences 2016; 5(03): 215 doi: 10.14260/jemds/2016/46
23
Hongtao Song, Cong Li, Rui Li, Jingshu Geng. Prognostic significance of AEG-1 expression in colorectal carcinomaInternational Journal of Colorectal Disease 2010; 25(10): 1201 doi: 10.1007/s00384-010-1009-3
24
D-W Yan, D-W Li, Y-X Yang, J Xia, X-L Wang, C-Z Zhou, J-W Fan, Y-G Wen, H-C Sun, Q Wang, G-Q Qiu, H-M Tang, Z-H Peng. Ubiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgeryBritish Journal of Cancer 2010; 103(7): 961 doi: 10.1038/sj.bjc.6605870
25
Y Apidianakis. Flies to Humans - Humans to Flies: A Virtuous Circle of Colorectal Cancer PreventionArchives of Clinical Gastroenterology 2017; : 047 doi: 10.17352/2455-2283.000038
26
Zahra Heidari, Hamidreza Mahmoudzadeh-Sagheb, Mehdi Jahantigh, Enam Alhagh Charkhat Gorgich. Immunohistochemical Expression of Ki67 and HER2 in Colorectal Cancer Compared to Adenomatous and Normal SamplesInternational Journal of Cancer Management 2017; 10(11) doi: 10.5812/ijcm.12252
27
Kim M Clark-Langone, Chithra Sangli, Jayadevi Krishnakumar, Drew Watson. Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX®Colon Cancer AssayBMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-691
28
C Evans, I Morrison, A G Heriot, J B Bartlett, C Finlayson, A G Dalgleish, D Kumar. The correlation between colorectal cancer rates of proliferation and apoptosis and systemic cytokine levels; plus their influence upon survivalBritish Journal of Cancer 2006; 94(10): 1412 doi: 10.1038/sj.bjc.6603104
29
Carlos A Rubio. Further studies on the arrest of cell proliferation in tumor cells at the invading front of colonic adenocarcinomaJournal of Gastroenterology and Hepatology 2007; 22(11): 1877 doi: 10.1111/j.1440-1746.2007.04839.x
30
Hai‐Hong Li, Gang Zhou, Xiao‐Bing Fu, Lei Zhang. Antigen expression of human eccrine sweat glandsJournal of Cutaneous Pathology 2009; 36(3): 318 doi: 10.1111/j.1600-0560.2008.01020.x
31
Siniša Maksimović, Branislava Jakovljević, Zdenka Gojković, Zlatko Maksimović. Immunohistochemical markers: Carcinoembryonic antigen, p53, Ki-67, and proliferating cell nuclear antigen as prognostic factors for colorectal cancerБиомедицинска истраживања 2018; 9(1): 8 doi: 10.7251/bii1801008m
32
Jussi Kasurinen, Ines Beilmann-Lehtonen, Tuomas Kaprio, Jaana Hagström, Caj Haglund, Camilla Böckelman. Phenotypic subtypes predict outcomes in colorectal cancerActa Oncologica 2023; 62(3): 245 doi: 10.1080/0284186X.2023.2183779
33
Jian ZHOU, Jie LI, Zengjun WANG, Changjun YIN, Wei ZHANG. Metadherin is a novel prognostic marker for bladder cancer progression and overall patient survivalAsia-Pacific Journal of Clinical Oncology 2012; 8(3) doi: 10.1111/j.1743-7563.2012.01541.x
34
Zhenyu He, Chuanbing Shi, Hao Wen, Fanglong Li, Baolin Wang, Jie Wang. The potential of carcinoembryonic antigen, p53, Ki-67 and glutathion Stransferase-π as clinico-histopathological markers for colorectal cancerJournal of Biomedical Research 2010; 24(1): 51 doi: 10.1016/S1674-8301(10)60008-5
35
Ling Deng, Rui Wang, Mingzhong Yang, Wei Li, Ling Zou. Ameloblastic carcinoma: Clinicopathological analysis of 18 cases and a systematic reviewHead & Neck 2019; 41(12): 4191 doi: 10.1002/hed.25926
36
Nara Rosana Andrade, Celina Tizuko Fujiyama Oshima, Thiago Simão Gomes, Ricardo Artigiani Neto, Nora Manoukian Forones. Imunoexpression of Ki-67 and p53 in Rectal Cancer Tissue After Treatment with Neoadjuvant ChemoradiationJournal of Gastrointestinal Cancer 2011; 42(1): 34 doi: 10.1007/s12029-010-9225-1
37
Maximino Redondo, Cristina Abitei, Teresa Téllez, Rafael Fúnez, Teresa Pereda, Isabel Rodrigo, Ana M Betancourt, Marilina García-Aranda, Antonio Rueda, Rafael Cayetano Martínez García, María Manuela Morales Suarez-Varela, Iñaki Zabalza, Matilde Sánchez del Charco, Juan José Borrero Martín, Raimundo García del Moral, Antonio Escobar, JoséMaría Quintana, Francisco Rivas-Ruiz. Clinical–pathological characteristics and short-term follow-up associated with proliferation, apoptosis and angiogenesis in a prospective cohort of patients with colorectal tumoursTumor Biology 2019; 41(4): 101042831983568 doi: 10.1177/1010428319835684
38
Cristina Bidian, Gabriela Adriana Filip, Luminița David, Bianca Moldovan, Diana Olteanu, Simona Clichici, Maria-Cristina Olănescu-Vaida-Voevod, Cristian Leostean, Sergiu Macavei, Dana Maria Muntean, Mihai Cenariu, Adriana Albu, Ioana Baldea. Green Synthesized Gold and Silver Nanoparticles Increased Oxidative Stress and Induced Cell Death in Colorectal Adenocarcinoma CellsNanomaterials 2023; 13(7): 1251 doi: 10.3390/nano13071251
39
M. S. Reimers, E. C. M. Zeestraten, P. J. K. Kuppen, G. J. Liefers, C. J. H. van de Velde. Biomarkers in precision therapy in colorectal cancerGastroenterology Report 2013; 1(3): 166 doi: 10.1093/gastro/got022
40
Renuka Patil, Shanthala P R, Prema Saldanha. IMMUNOHISTOCHEMICAL MARKERS OF CLINICAL SIGNIFICANCE IN CARCINOMA OF THE COLON AND RECTUMJournal of Evolution of Medical and Dental Sciences 2016; 5(96): 7087 doi: 10.14260/jemds/2016/1603
41
Li Bian, Tao Wang, Shao-hua Zhang, Hui-qiang Zhang, Yun-fei Guo, Ge Du, Wang Li, Shi-kai Wu, San-tai Song, Ze-fei Jiang. Ki-67 index as a prognostic factor of subsequent lapatinib-based therapy in HER2-positive metastatic breast cancer with resistance to trastuzumabCancer Biology & Therapy 2014; 15(4): 365 doi: 10.4161/cbt.27624
42
Meng-Yao Ji, Lei Yuan, Shi-Min Lu, Meng-Ting Gao, Zhi Zeng, Na Zhan, Yi-Juan Ding, Zheng-Ru Liu, Ping-Xiao Huang, Cheng Lu, Wei-Guo Dong. Glandular orientation and shape determined by computational pathology could identify aggressive tumor for early colon carcinoma: a triple-center studyJournal of Translational Medicine 2020; 18(1) doi: 10.1186/s12967-020-02297-w